Grant: Doctoral Research Award: Canada Graduate Scholarships
McMaster University
$120,000.00
Controlled Pulse-Parameter Transcranial Magnetic Stimulation to alleviate pain in fibromyalgia
FY 2024-25
Summary
Fibromyalgia is a debilitating musculoskeletal syndrome characterized by chronic pain, stiffness, fatigue, and depressed mood. Fibromyalgia affects 1.7% of Canadians, with a higher prevalence in females compared to males at a 9:1 ratio. The etiology is not well defined and chronic pain in fibromyalgia arises in the absence of tissue pathology, and consequently a lack of consensus on reliable diagnostic criteria. Current treatments often provide limited relief with adverse effects. High-frequency repetitive Transcranial Magnetic Stimulation (rTMS) is investigated as a therapeutic method for chronic pain to achieve analgesic-like effects. Studies targeting the primary motor cortex (M1) with rTMS have demonstrated reduced pain perception in fibromyalgia patients, though findings are inconsistent. Controlled pulse parameter TMS (cTMS) builds upon traditional rTMS, to induce more profound and longer-lasting changes in cortical excitability. Monophasic pulses activate more uniform populations of interneurons, leading to a cumulative effect that has greater changes in synaptic strength and neuronal activity. Thus, the proposed study aims to investigate the impact of a two-week intervention, 10 sessions in total, of active versus sham 10 Hz cTMS in individuals with fibromyalgia. Participants will be pseudo-randomized into active or sham cTMS groups and outcomes will be taken before, immediately following, and 3 months post-intervention. The primary outcome includes pain intensity, assessed using a numerical rating scale. Secondary outcomes include the Fibromyalgia Impact Questionnaire (FIQ), Euro 5-QoL, PROMIS-29 v2.1, activity levels, and patient-perceived global index of change (PGIC). This research could ultimately disrupt the pain cycle, enhancing daily activities and overall quality of life for individuals with fibromyalgia. In addition, this could pave the way for the development of future treatment protocols changing the landscape of chronic pain management.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
518217
Name
Drapeau Chloe C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Controlled Pulse-Parameter Transcranial Magnetic Stimulation to alleviate pain in fibromyalgia
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Chronic Pain; Ctms; Excitability; Fibromyalgia; Inhibition; Neuromodulation; Neurophysiology; Non-Invasive Brain Stimulation; Rtms; Transcrainial Magnetic Stimulation
Abstract
Fibromyalgia is a debilitating musculoskeletal syndrome characterized by chronic pain, stiffness, fatigue, and depressed mood. Fibromyalgia affects 1.7% of Canadians, with a higher prevalence in females compared to males at a 9:1 ratio. The etiology is not well defined and chronic pain in fibromyalgia arises in the absence of tissue pathology, and consequently a lack of consensus on reliable diagnostic criteria. Current treatments often provide limited relief with adverse effects. High-frequency repetitive Transcranial Magnetic Stimulation (rTMS) is investigated as a therapeutic method for chronic pain to achieve analgesic-like effects. Studies targeting the primary motor cortex (M1) with rTMS have demonstrated reduced pain perception in fibromyalgia patients, though findings are inconsistent. Controlled pulse parameter TMS (cTMS) builds upon traditional rTMS, to induce more profound and longer-lasting changes in cortical excitability. Monophasic pulses activate more uniform populations of interneurons, leading to a cumulative effect that has greater changes in synaptic strength and neuronal activity. Thus, the proposed study aims to investigate the impact of a two-week intervention, 10 sessions in total, of active versus sham 10 Hz cTMS in individuals with fibromyalgia. Participants will be pseudo-randomized into active or sham cTMS groups and outcomes will be taken before, immediately following, and 3 months post-intervention. The primary outcome includes pain intensity, assessed using a numerical rating scale. Secondary outcomes include the Fibromyalgia Impact Questionnaire (FIQ), Euro 5-QoL, PROMIS-29 v2.1, activity levels, and patient-perceived global index of change (PGIC). This research could ultimately disrupt the pain cycle, enhancing daily activities and overall quality of life for individuals with fibromyalgia. In addition, this could pave the way for the development of future treatment protocols changing the landscape of chronic pain management.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Drapeau, Chloe C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~